Insulin Treatment Appraisal Scale for Type 2 Diabetes
Author Information
Author(s): Snoek Frank J, Skovlund Søren E, Pouwer Frans
Primary Institution: VU University Medical Center Amsterdam
Hypothesis
The insulin treatment appraisal scale (ITAS) was developed to assess patients' perceptions of insulin therapy in type 2 diabetes.
Conclusion
The ITAS is a reliable and valid tool for assessing both positive and negative perceptions of insulin treatment in patients with type 2 diabetes.
Supporting Evidence
- The ITAS showed high internal consistency with a Cronbach's alpha of 0.89.
- Patients using insulin had significantly less negative appraisals than insulin naive patients.
- The study confirmed concurrent validity with significant correlations between ITAS scores and other measures of emotional distress.
Takeaway
This study created a questionnaire to help understand how people with diabetes feel about insulin treatment, showing that those on insulin tend to have a better view of it than those who are not.
Methodology
282 patients with type 2 diabetes completed the ITAS and other psychological measures; reliability and validity were tested using exploratory factor analysis and correlation coefficients.
Potential Biases
The sample may not be representative due to the low response rate and limited diversity.
Limitations
The study had a low response rate of 29% and included a limited ethnic background, which may bias the results.
Participant Demographics
Mean age was 59 years, 54% were female, and the average duration of diabetes was 5.1 years.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website